NVIV
InVivo Therapeutics Holdings Corp
NVIV
NVIV
Delisted
NVIV was delisted on the 12th of February, 2024.
28 hedge funds and large institutions have $3.04M invested in InVivo Therapeutics Holdings Corp in 2017 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $3K
Holders
28
Holding in Top 10
–
Calls
–
Puts
$3K
Top Buyers
| 1 | +$162K | |
| 2 | +$92.6K | |
| 3 | +$46.3K | |
| 4 |
Bank of New York Mellon
New York
|
+$23.1K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$23.1K |
Top Sellers
| 1 | -$324K | |
| 2 | -$208K | |
| 3 | -$116K | |
| 4 |
ARTA
A.R.T. Advisors
New York
|
-$78K |
| 5 |
BBA
Baker Bros. Advisors
New York
|
-$69.4K |